Shin-Etsu Chemical (4063) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
13 Jun, 2025Executive summary
Net sales for Q1 FY2025 were ¥597.9 billion, down 0.2% year-over-year; operating income was ¥191.0 billion, up 0.1% year-over-year.
Net income attributable to owners of parent was ¥144.0 billion, a 6.3% decrease year-over-year.
Comprehensive income surged 76.6% to ¥326.6 billion, mainly due to foreign currency translation gains.
Overseas sales accounted for 79% of total net sales in Q1.
Financial highlights
Gross profit was ¥242.6 billion, up slightly from ¥241.2 billion year-over-year.
Ordinary income rose 1.2% to ¥219.8 billion.
Net assets increased to ¥4,635.7 billion, with a stockholders' equity ratio of 83.6%.
Cash and time deposits stood at ¥1,684.0 billion at quarter-end.
Dividend forecast for FY2025 raised to ¥106 per share, up ¥6 from the previous year.
Outlook and guidance
FY2025 net sales forecast at ¥2,500.0 billion (+3.5%), operating income at ¥735.0 billion (+4.8%), and net income at ¥533.0 billion (+2.5%).
Annual dividend forecast of ¥106 per share, reflecting a 40% payout ratio.
Management notes ongoing global economic uncertainty, currency fluctuations, and market volatility as key variables.
Latest events from Shin-Etsu Chemical
- Operating and net income fell despite stable sales, with segment results mixed across markets.4063
Q3 202627 Jan 2026 - Sales up, profits down amid margin pressure and volatile global markets; guidance unchanged.4063
Q2 202624 Oct 2025 - Revenue rose 5% year-over-year, but profit margins and net income declined amid global headwinds.4063
Q1 202624 Jul 2025 - Sales and profits rose, but net income slipped on tax; full-year guidance and investments unchanged.4063
Q2 202513 Jun 2025 - Earnings and cash flow hit record highs, with strong electronics growth and major share buybacks.4063
Q4 20256 Jun 2025 - Net sales and net income rose year-over-year, with robust segment growth and higher dividends.4063
Q3 20255 Jun 2025